{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Silybum marianum", "comprehensive utilization", "pharmacology", "phytochemistry", "synthetic biology"]], "OtherAbstract": [], "SpaceFlightMission": [], "InvestigatorList": [], "CitationSubset": [], "OtherID": [], "GeneralNote": [], "PMID": "39055491", "DateRevised": {"Year": "2024", "Month": "07", "Day": "27"}, "Article": {"Language": ["eng"], "ELocationID": ["1417655", "10.3389/fphar.2024.1417655"], "ArticleDate": [{"Year": "2024", "Month": "07", "Day": "11"}], "Journal": {"ISSN": "1663-9812", "JournalIssue": {"Volume": "15", "PubDate": {"Year": "2024"}}, "Title": "Frontiers in pharmacology", "ISOAbbreviation": "Front Pharmacol"}, "ArticleTitle": "A review of the botany, phytochemistry, pharmacology, synthetic biology and comprehensive utilization of <i>Silybum marianum</i>.", "Pagination": {"StartPage": "1417655", "MedlinePgn": "1417655"}, "Abstract": {"AbstractText": ["<i>Silybum marianum</i> (L.) Gaertn, a herbaceous plant with a long history in traditional medicine for the treatment of hepatobiliary diseases, particularly in Europe, which has attracted attention for its remarkable therapeutic effect. This review systematically summarizes the research progress in the botany, phytochemistry, pharmacology, comprehensive utilization and synthetic biology of <i>S</i>. <i>marianum</i>. Up to now, more than 20 types of flavonolignan components have been isolated from <i>S</i>. <i>marianum</i>. In addition, the rearch on fatty acids and triterpenoids is also constantly improving. Among them, silybin is the most active compound in flavonolignans components. Its pharmacological effects <i>in vivo</i> and <i>in vitro</i> include anti-inflammatory, antioxidant, anti-tumour, hypoglycaemic, neuroprotective and immunoregulatory properties. The use of coniferyl alcohol and taxifolin as substrates to produce silybin and isosilybin under the action of enzyme catalysis is the commonly used biosynthetic pathway of silymarin, which provides support for a comprehensive analysis of the synthetic pathway of silymarin. In addition to medicinal use, the extracts of plants also have broad application prospects in the production of food, healthcare products, cosmetics and other aspects. In addition, the chemical composition, pharmacological mechanism and synthetic biology of <i>S. marianum</i> need to be further studied, which is very important for its clinical efficacy and resource development."], "CopyrightInformation": "Copyright \u00a9 2024 Zhang, Liu, Wang, Wang, Kong, Wu, Wu, Ma, Jiang, Ren, Du, Ma and Liu."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin, China."}], "LastName": "Zhang", "ForeName": "Xiaozhuang", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin, China."}], "LastName": "Liu", "ForeName": "Meiqi", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin, China."}], "LastName": "Wang", "ForeName": "Zhen", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin, China."}], "LastName": "Wang", "ForeName": "Panpan", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin, China."}], "LastName": "Kong", "ForeName": "Lingyang", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin, China."}], "LastName": "Wu", "ForeName": "Jianhao", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin, China."}], "LastName": "Wu", "ForeName": "Wei", "Initials": "W"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin, China."}], "LastName": "Ma", "ForeName": "Lengleng", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin, China."}], "LastName": "Jiang", "ForeName": "Shan", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin, China."}], "LastName": "Ren", "ForeName": "Weichao", "Initials": "W"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "First Affiliated Hospital, Heilongjiang University of Chinese Medicine, Harbin, China."}], "LastName": "Du", "ForeName": "Likun", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin, China."}], "LastName": "Ma", "ForeName": "Wei", "Initials": "W"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Jiamusi, Heilongjiang University of Chinese Medicine, Jiamusi, China."}], "LastName": "Liu", "ForeName": "Xiubo", "Initials": "X"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Front Pharmacol", "NlmUniqueID": "101548923", "ISSNLinking": "1663-9812"}, "CoiStatement": "The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Abenavoli L., Capasso R., Milic N., Capasso F. (2010). Milk thistle in liver diseases: past, present, future. Phytother. Res. 24 (10), 1423\u20131432. 10.1002/ptr.3207", "ArticleIdList": ["10.1002/ptr.3207", "20564545"]}, {"Citation": "Abenavoli L., Izzo A. A., Mili\u0107 N., Cicala C., Santini A., Capasso R. (2018). Milk thistle (Silybum marianum): a concise overview on its chemistry, pharmacological, and nutraceutical uses in liver diseases. Phytother. Res. 32 (11), 2202\u20132213. 10.1002/ptr.6171", "ArticleIdList": ["10.1002/ptr.6171", "30080294"]}, {"Citation": "Alarcon de la Lastra C., Martin M. J., Marhuenda E. (1992). Gastric anti-ulcer activity of silymarin, a lipoxygenase inhibitor, in rats. J. Pharm. Pharmacol. 44 (11), 929\u2013931. 10.1111/j.2042-7158.1992.tb03239.x", "ArticleIdList": ["10.1111/j.2042-7158.1992.tb03239.x", "1361540"]}, {"Citation": "Alberti K. G., Zimmet P. Z. (1998). Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet. Med. 15 (7), 539\u2013553. 10.1002/(sici)1096-9136(199807)15:7<539::Aid-dia668>3.0.Co;2-s", "ArticleIdList": ["10.1002/(sici)1096-9136(199807)15:7<539::Aid-dia668>3.0.Co;2-s", "9686693"]}, {"Citation": "Arnone A., Merlini L., Zanarotti A. (1979). Constituents of Silybum marianum. Structure of isosilybin and stereochemistry of silybin. J. Chem. Soc. Chem. Commun. (16), 696\u2013697. 10.1039/C39790000696", "ArticleIdList": ["10.1039/C39790000696"]}, {"Citation": "Bachelder R. E., Ribick M. J., Marchetti A., Falcioni R., Soddu S., Davis K. R., et al. (1999). p53 inhibits alpha 6 beta 4 integrin survival signaling by promoting the caspase 3-dependent cleavage of AKT/PKB. J. Cell Biol. 147 (5), 1063\u20131072. 10.1083/jcb.147.5.1063", "ArticleIdList": ["10.1083/jcb.147.5.1063", "PMC2169339", "10579725"]}, {"Citation": "Ball K. R., Kowdley K. V. (2005). A review of Silybum marianum (milk thistle) as a treatment for alcoholic liver disease. J. Clin. Gastroenterology 39 (6), 520\u2013528. 10.1097/01.mcg.0000165668.79530.a0", "ArticleIdList": ["10.1097/01.mcg.0000165668.79530.a0", "15942440"]}, {"Citation": "Begum S. A., Sahai M., Ray A. B. (2010). Non-conventional lignans: coumarinolignans, flavonolignans, and stilbenolignans. Fortschritte der Chemie organischer Naturstoffe/Prog. Chem. Org. Nat. Prod. 93, 1\u201370. 10.1007/978-3-7091-0140-7_1", "ArticleIdList": ["10.1007/978-3-7091-0140-7_1", "20556676"]}, {"Citation": "Bencze-Nagy J., Strifler P., Horv\u00e1th B., Such N., Farkas V., Dublecz K., et al. (2023). Effects of dietary milk thistle (Silybum marianum) supplementation in ducks fed mycotoxin-contaminated diets. Vet. Sci. 10 (2), 100. 10.3390/vetsci10020100", "ArticleIdList": ["10.3390/vetsci10020100", "PMC9967284", "36851404"]}, {"Citation": "Biedermann D., Vav\u0159\u00edkov\u00e1 E., Cvak L., K\u0159en V. (2014). Chemistry of silybin. Nat. Prod. Rep. 31 (9), 1138\u20131157. 10.1039/c3np70122k", "ArticleIdList": ["10.1039/c3np70122k", "24977260"]}, {"Citation": "Bittencourt M. L. F., Rodrigues R. P., Kitagawa R. R., Gon\u00e7alves R. C. R. (2020). The gastroprotective potential of silibinin against Helicobacter pylori infection and gastric tumor cells. Life Sci. 256, 117977. 10.1016/j.lfs.2020.117977", "ArticleIdList": ["10.1016/j.lfs.2020.117977", "32603822"]}, {"Citation": "Borah A., Paul R., Choudhury S., Choudhury A., Bhuyan B., Das Talukdar A., et al. (2013). Neuroprotective potential of silymarin against CNS disorders: insight into the pathways and molecular mechanisms of action. CNS Neurosci. Ther. 19 (11), 847\u2013853. 10.1111/cns.12175", "ArticleIdList": ["10.1111/cns.12175", "PMC6493565", "24118806"]}, {"Citation": "Cartee L., Wang Z., Decker R. H., Chellappan S. P., Fusaro G., Hirsch K. G., et al. (2001). The cyclin-dependent kinase inhibitor (CDKI) flavopiridol disrupts phorbol 12-myristate 13-acetate-induced differentiation and CDKI expression while enhancing apoptosis in human myeloid leukemia cells. Cancer Res. 61 (6), 2583\u20132591.", "ArticleIdList": ["11289135"]}, {"Citation": "Chambers C. S., Holeckova V., Petraskova L., Biedermann D., Valentova K., Buchta M., et al. (2017). The silymarin composition. and why does it matter? Food Res. Int. 100 (Pt 3), 339\u2013353. 10.1016/j.foodres.2017.07.017", "ArticleIdList": ["10.1016/j.foodres.2017.07.017", "28964357"]}, {"Citation": "Chen Y., Wang C. (1998). Basic research on comprehensive utilization of milk thistle II fruit oil and protein. Acta Agric. Boreali-Occidentalis Sin. (01), 84\u201386."}, {"Citation": "Cheung C. W., Vesey D. A., Nicol D. L., Johnson D. W. (2007). Silibinin inhibits renal cell carcinoma via mechanisms that are independent of insulin\u2010like growth factor\u2010binding protein 3. BJU Int. 99 (2), 454\u2013460. 10.1111/j.1464-410X.2007.06571.x", "ArticleIdList": ["10.1111/j.1464-410X.2007.06571.x", "17313429"]}, {"Citation": "Chinni S. R., Li Y., Upadhyay S., Koppolu P. K., Sarkar F. H. (2001). Indole-3-carbinol (I3C) induced cell growth inhibition, G1 cell cycle arrest and apoptosis in prostate cancer cells. Oncogene 20 (23), 2927\u20132936. 10.1038/sj.onc.1204365", "ArticleIdList": ["10.1038/sj.onc.1204365", "11420705"]}, {"Citation": "Chittezhath M., Deep G., Singh R. P., Agarwal C., Agarwal R. (2008). Silibinin inhibits cytokine-induced signaling cascades and down-regulates inducible nitric oxide synthase in human lung carcinoma A549 cells. Mol. Cancer Ther. 7 (7), 1817\u20131826. 10.1158/1535-7163.Mct-08-0256", "ArticleIdList": ["10.1158/1535-7163.Mct-08-0256", "PMC2587409", "18644994"]}, {"Citation": "Choi S., Ham S., Lee Y. I., Kim J., Lee W. J., Lee J. H. (2023). Silibinin downregulates types I and III collagen expression via suppression of the mTOR signaling pathway. Int. J. Mol. Sci. 24 (18), 14386. 10.3390/ijms241814386", "ArticleIdList": ["10.3390/ijms241814386", "PMC10531945", "37762688"]}, {"Citation": "Committee N. P. (2020). Chinese pharmacopoeia. Beijing: China Medical Science and Technology Press."}, {"Citation": "Conserva F., Gesualdo L., Papale M. (2016). A systems biology overview on human diabetic nephropathy: from genetic susceptibility to post-transcriptional and post-translational modifications. J. Diabetes Res. 2016, 7934504. 10.1155/2016/7934504", "ArticleIdList": ["10.1155/2016/7934504", "PMC4698547", "26798653"]}, {"Citation": "Cotton J., Spandau D. F. (1997). Ultraviolet B-radiation dose influences the induction of apoptosis and p53 in human keratinocytes. Radiat. Res. 147 (2), 148\u2013155. 10.2307/3579415", "ArticleIdList": ["10.2307/3579415", "9008206"]}, {"Citation": "Csupor D., Csorba A., Hohmann J. (2016). Recent advances in the analysis of flavonolignans of Silybum marianum. J. Pharm. Biomed. Analysis 130, 301\u2013317. 10.1016/j.jpba.2016.05.034", "ArticleIdList": ["10.1016/j.jpba.2016.05.034", "27321822"]}, {"Citation": "Dahmani R., Just P. A., Perret C. (2011). The Wnt/\u03b2-catenin pathway as a therapeutic target in human hepatocellular carcinoma. Clin. Res. Hepatol. Gastroenterol. 35 (11), 709\u2013713. 10.1016/j.clinre.2011.05.010", "ArticleIdList": ["10.1016/j.clinre.2011.05.010", "21778132"]}, {"Citation": "Dan W., Fan Y., Hou T., Wei Y., Liu B., Que T., et al. (2022). Silibinin inhibits the migration, invasion and epithelial-mesenchymal transition of prostate cancer by activating the autophagic degradation of YAP. J. Cancer 13 (13), 3415\u20133426. 10.7150/jca.63514", "ArticleIdList": ["10.7150/jca.63514", "PMC9608209", "36313039"]}, {"Citation": "de Avelar C. R., Nunes B. V. C., da Silva Sassaki B., Dos Santos Vasconcelos M., de Oliveira L. P. M., Lyra A. C., et al. (2023). Efficacy of silymarin in patients with non-alcoholic fatty liver disease - the Siliver trial: a study protocol for a randomized controlled clinical trial. Trials 24 (1), 177. 10.1186/s13063-023-07210-6", "ArticleIdList": ["10.1186/s13063-023-07210-6", "PMC10000352", "36899430"]}, {"Citation": "Dhanalakshmi S., Mallikarjuna G. U., Singh R. P., Agarwal R. (2004). Silibinin prevents ultraviolet radiation-caused skin damages in SKH-1 hairless mice via a decrease in thymine dimer positive cells and an up-regulation of p53-p21/Cip1 in epidermis. Carcinogenesis 25 (8), 1459\u20131465. 10.1093/carcin/bgh152", "ArticleIdList": ["10.1093/carcin/bgh152", "15033902"]}, {"Citation": "Dietzmann J., Thiel U., Ansorge S., Neumann K. H., T\u00e4ger M. (2002). Thiol-inducing and immunoregulatory effects of flavonoids in peripheral blood mononuclear cells from patients with end-stage diabetic nephropathy. Free Radic. Biol. Med. 33 (10), 1347\u20131354. 10.1016/s0891-5849(02)01043-2", "ArticleIdList": ["10.1016/s0891-5849(02)01043-2", "12419466"]}, {"Citation": "Drouet S., Leclerc E. A., Garros L., Tungmunnithum D., Kabra A., Abbasi B. H., et al. (2019). A green ultrasound-assisted extraction optimization of the natural antioxidant and anti-aging flavonolignans from milk thistle Silybum marianum (L.) Gaertn. Fruits for cosmetic applications. Antioxidants 8 (8), 304. 10.3390/antiox8080304", "ArticleIdList": ["10.3390/antiox8080304", "PMC6721202", "31416140"]}, {"Citation": "Drouet S., Tungmunnithum D., Lain\u00e9 \u00c9., Hano C. (2020). Gene expression analysis and metabolite profiling of silymarin biosynthesis during milk thistle (Silybum marianum (L.) Gaertn.) fruit ripening. Int. J. Mol. Sci. 21 (13), 4730. 10.3390/ijms21134730", "ArticleIdList": ["10.3390/ijms21134730", "PMC7370286", "32630801"]}, {"Citation": "Faixov\u00e1 D., Ratvaj M., Maru\u0161\u010d\u00e1kov\u00e1 I. C., Hr\u010dkov\u00e1 G., Karaffov\u00e1 V., Faixov\u00e1 Z., et al. (2023). Silybin showed higher cytotoxic, antiproliferative, and anti-inflammatory activities in the CaCo cancer cell line while retaining viability and proliferation in normal intestinal IPEC-1 cells. Life (Basel) 13 (2), 492. 10.3390/life13020492", "ArticleIdList": ["10.3390/life13020492", "PMC9964225", "36836848"]}, {"Citation": "Fallah M., Davoodvandi A., Nikmanzar S., Aghili S., Mirazimi S. M. A., Aschner M., et al. (2021). Silymarin (milk thistle extract) as a therapeutic agent in gastrointestinal cancer. Biomed. Pharmacother. 142, 112024. 10.1016/j.biopha.2021.112024", "ArticleIdList": ["10.1016/j.biopha.2021.112024", "PMC8458260", "34399200"]}, {"Citation": "Fan S., Li L., Chen S., Yu Y., Qi M., Tashiro S.-I., et al. (2011). Silibinin induced-autophagic and apoptotic death is associated with an increase in reactive oxygen and nitrogen species in HeLa cells. Free Radic. Res. 45 (11-12), 1307\u20131324. 10.3109/10715762.2011.618186", "ArticleIdList": ["10.3109/10715762.2011.618186", "21875385"]}, {"Citation": "Fan Y., Hou T., Dan W., Liu T., Luan J., Liu B., et al. (2020). Silibinin inhibits epithelial\u2011mesenchymal transition of renal cell carcinoma through autophagy-dependent Wnt/\u03b2-catenin signaling. Int. J. Mol. Med. 45 (5), 1341\u20131350. 10.3892/ijmm.2020.4521", "ArticleIdList": ["10.3892/ijmm.2020.4521", "PMC7138295", "32323735"]}, {"Citation": "Feng R., Chen J. H., Liu C. H., Xia F. B., Xiao Z., Zhang X., et al. (2019). A combination of Pueraria lobata and Silybum marianum protects against alcoholic liver disease in mice. Phytomedicine 58, 152824. 10.1016/j.phymed.2019.152824", "ArticleIdList": ["10.1016/j.phymed.2019.152824", "30836218"]}, {"Citation": "Flora K., Hahn M., Rosen H., Benner K. (1998). Milk thistle (Silybum marianum) for the therapy of liver disease. Am. J. Gastroenterol. 93 (2), 139\u2013143. 10.1111/j.1572-0241.1998.00139.x", "ArticleIdList": ["10.1111/j.1572-0241.1998.00139.x", "9468229"]}, {"Citation": "Fotedar R., Bendjennat M., Fotedar A. (2004). Role of p21WAF1 in the cellular response to UV. Cell Cycle 3 (2), 132\u2013135. 10.4161/cc.3.2.658", "ArticleIdList": ["10.4161/cc.3.2.658", "14712074"]}, {"Citation": "G\u00e1ndara L., Sandes E., Di Venosa G., Prack Mc Cormick B., Rodriguez L., Mamone L., et al. (2014). The natural flavonoid silybin improves the response to Photodynamic Therapy of bladder cancer cells. J. Photochem Photobiol. B 133, 55\u201364. 10.1016/j.jphotobiol.2014.03.006", "ArticleIdList": ["10.1016/j.jphotobiol.2014.03.006", "24705371"]}, {"Citation": "Gharagozloo M., Velardi E., Bruscoli S., Agostini M., Di Sante M., Donato V., et al. (2010). Silymarin suppress CD4+ T cell activation and proliferation: effects on NF-kappaB activity and IL-2 production. Pharmacol. Res. 61 (5), 405\u2013409. 10.1016/j.phrs.2009.12.017", "ArticleIdList": ["10.1016/j.phrs.2009.12.017", "20056147"]}, {"Citation": "Gioti K., Papachristodoulou A., Benaki D., Havaki S., Beloukas A., Vontzalidou A., et al. (2019). Silymarin enriched extract (Silybum marianum) additive effect on doxorubicin-mediated cytotoxicity in PC-3 prostate cancer cells. Planta Med. 85 (11-12), 997\u20131007. 10.1055/a-0954-6704", "ArticleIdList": ["10.1055/a-0954-6704", "31288278"]}, {"Citation": "Gj\u00f6rloff Wingren A., Ziyad Faik R., Holefors A., Filecovic E., Gustafsson A. (2023). In vitro effects of undifferentiated callus extracts from Plantago major L, Rhodiola rosea L and Silybum marianum L in normal and malignant human skin cells. Heliyon 9 (6), e16480. 10.1016/j.heliyon.2023.e16480", "ArticleIdList": ["10.1016/j.heliyon.2023.e16480", "PMC10245016", "37292297"]}, {"Citation": "Graves P. R., Yu L., Schwarz J. K., Gales J., Sausville E. A., O'Connor P. M., et al. (2000). The Chk1 protein kinase and the Cdc25C regulatory pathways are targets of the anticancer agent UCN-01. J. Biol. Chem. 275 (8), 5600\u20135605. 10.1074/jbc.275.8.5600", "ArticleIdList": ["10.1074/jbc.275.8.5600", "10681541"]}, {"Citation": "Gu M., Zhao P., Huang J., Zhao Y., Wang Y., Li Y., et al. (2016). Silymarin ameliorates metabolic dysfunction associated with diet-induced obesity via activation of farnesyl X receptor. Front. Pharmacol. 7, 345. 10.3389/fphar.2016.00345", "ArticleIdList": ["10.3389/fphar.2016.00345", "PMC5039206", "27733832"]}, {"Citation": "Guo J., Yang X. (2008). Research progress on the protective effect of flavonoids on experimental liver injury in animals. Chin. Pharmacol. Bull. (01), 5\u201310."}, {"Citation": "Guo Y., Wang S., Wang Y., Zhu T. (2016). Silymarin improved diet-induced liver damage and insulin resistance by decreasing inflammation in mice. Pharm. Biol. 54 (12), 2995\u20133000. 10.1080/13880209.2016.1199042", "ArticleIdList": ["10.1080/13880209.2016.1199042", "27387273"]}, {"Citation": "Gupta O. P., Sing S., Bani S., Sharma N., Malhotra S., Gupta B. D., et al. (2000). Anti-inflammatory and anti-arthritic activities of silymarin acting through inhibition of 5-lipoxygenase. Phytomedicine 7 (1), 21\u201324. 10.1016/s0944-7113(00)80017-3", "ArticleIdList": ["10.1016/s0944-7113(00)80017-3", "10782486"]}, {"Citation": "Hammerbacher A., Kandasamy D., Ullah C., Schmidt A., Wright L. P., Gershenzon J. (2019). Flavanone-3-Hydroxylase plays an important role in the biosynthesis of spruce phenolic defenses against bark beetles and their fungal associates. Front. Plant Sci. 10, 208. 10.3389/fpls.2019.00208", "ArticleIdList": ["10.3389/fpls.2019.00208", "PMC6397876", "30858861"]}, {"Citation": "Han K., Li C., Zhang X., Shang L. (2019). DUXAP10 inhibition attenuates the proliferation and metastasis of hepatocellular carcinoma cells by regulation of the Wnt/\u03b2-catenin and PI3K/Akt signaling pathways. Biosci. Rep. 39 (5). 10.1042/bsr20181457", "ArticleIdList": ["10.1042/bsr20181457", "PMC6542759", "30996112"]}, {"Citation": "Hanafy N. A. N., El-Kemary M. A. (2022). Silymarin/curcumin loaded albumin nanoparticles coated by chitosan as muco-inhalable delivery system observing anti-inflammatory and anti COVID-19 characterizations in oleic acid triggered lung injury and in vitro COVID-19 experiment. Int. J. Biol. Macromol. 198, 101\u2013110. 10.1016/j.ijbiomac.2021.12.073", "ArticleIdList": ["10.1016/j.ijbiomac.2021.12.073", "PMC8712435", "34968533"]}, {"Citation": "Hermanto U., Zong C. S., Wang L. H. (2001). ErbB2-overexpressing human mammary carcinoma cells display an increased requirement for the phosphatidylinositol 3-kinase signaling pathway in anchorage-independent growth. Oncogene 20 (51), 7551\u20137562. 10.1038/sj.onc.1204964", "ArticleIdList": ["10.1038/sj.onc.1204964", "11709727"]}, {"Citation": "Hii S. I., Nicol D. L., Gotley D. C., Thompson L. C., Green M. K., Jonsson J. R. (1998). Captopril inhibits tumour growth in a xenograft model of human renal cell carcinoma. Br. J. Cancer 77 (6), 880\u2013883. 10.1038/bjc.1998.145", "ArticleIdList": ["10.1038/bjc.1998.145", "PMC2150111", "9528828"]}, {"Citation": "Imai-Sumida M., Chiyomaru T., Majid S., Saini S., Nip H., Dahiya R., et al. (2017). Silibinin suppresses bladder cancer through down-regulation of actin cytoskeleton and PI3K/Akt signaling pathways. Oncotarget 8 (54), 92032\u201392042. 10.18632/oncotarget.20734", "ArticleIdList": ["10.18632/oncotarget.20734", "PMC5696161", "29190895"]}, {"Citation": "Javed S., Kohli K., Ali M. (2011). Reassessing bioavailability of silymarin. Altern. Med. Rev. 16 (3), 239\u2013249.", "ArticleIdList": ["21951025"]}, {"Citation": "Javeed A., Ahmed M., Sajid A. R., Sikandar A., Aslam M., Hassan T. U., et al. (2022). Comparative assessment of phytoconstituents, antioxidant activity and chemical analysis of different parts of milk thistle Silybum marianum L. Molecules 27 (9), 2641. 10.3390/molecules27092641", "ArticleIdList": ["10.3390/molecules27092641", "PMC9102823", "35565993"]}, {"Citation": "Jin L., Si-li Y., Ya-ting M., Tie-jun Z., Guang-rong Z. (2016). Research progress in metabolic engineering and synthetic biology for natural lignan production. Chin. Traditional Herb. Drugs. Chin. Herb. Med. 47 (14), 2556\u20132562."}, {"Citation": "Kalinowska M., P\u0142o\u0144ska A., Trusiak M., Go\u0142\u0119biewska E., Gorlewska-Pietluszenko A. (2022). Comparing the extraction methods, chemical composition, phenolic contents and antioxidant activity of edible oils from Cannabis sativa and Silybum marianu seeds. Sci. Rep. 12 (1), 20609. 10.1038/s41598-022-25030-7", "ArticleIdList": ["10.1038/s41598-022-25030-7", "PMC9708685", "36446937"]}, {"Citation": "Kaloga M. (1981). Isosilychristin, ein neues Flayonolignan aus Silybum marianum L. Gaertn./Isosilychristin, a New Flavonolignan from Silybum marianum L.Gaertn./Isosilychristin, a New Flavonolignan Silybum marianum L.Gaertn. 36(2), 262\u2013265. 10.1515/znb-1981-0225", "ArticleIdList": ["10.1515/znb-1981-0225"]}, {"Citation": "Karem H. A., Omar F. K., Ahmad S. A., Nizar M. M., Ahmed A.A.-S. (2021). Anticancer and antimutagenic activity of Silybum marianum L. and Eucalyptus camaldulensis Dehnh. against skin cancer induced by DMBA: in vitro and in vivo models. Pak J. Pharm. Sci. 34 (3), 987\u2013993.", "ArticleIdList": ["34602423"]}, {"Citation": "Karimzadeh M. R., Masoudi Chelegahi A., Shahbazi S., Reiisi S. (2024). Co-treatment of silymarin and cisplatin inhibited cell proliferation, induced apoptosis in ovarian cancer. Mol. Biol. Rep. 51 (1), 118. 10.1007/s11033-023-09026-8", "ArticleIdList": ["10.1007/s11033-023-09026-8", "38227082"]}, {"Citation": "Khalil M. R., El-Demerdash R. S., Elminshawy H. H., Mehanna E. T., Mesbah N. M., Abo-Elmatty D. M. (2021). Therapeutic effect of bone marrow mesenchymal stem cells in a rat model of carbon tetrachloride induced liver fibrosis. Biomed. J. 44 (5), 598\u2013610. 10.1016/j.bj.2020.04.011", "ArticleIdList": ["10.1016/j.bj.2020.04.011", "PMC8640564", "32389821"]}, {"Citation": "Kim S. H., Choo G. S., Yoo E. S., Woo J. S., Han S. H., Lee J. H., et al. (2019). Silymarin induces inhibition of growth and apoptosis through modulation of the MAPK signaling pathway in AGS human gastric cancer cells. Oncol. Rep. 42 (5), 1904\u20131914. 10.3892/or.2019.7295", "ArticleIdList": ["10.3892/or.2019.7295", "PMC6775811", "31485597"]}, {"Citation": "Kim S. H., Choo G. S., Yoo E. S., Woo J. S., Lee J. H., Han S. H., et al. (2021). Silymarin inhibits proliferation of human breast cancer cells via regulation of the MAPK signaling pathway and induction of apoptosis. Oncol. Lett. 21 (6), 492. 10.3892/ol.2021.12753", "ArticleIdList": ["10.3892/ol.2021.12753", "PMC8100955", "33968208"]}, {"Citation": "Krepkova L. V., Babenko A. N., Saybel\u2019 O. L., Lupanova I. A., Kuzina O. S., Job K. M., et al. (2021). Valuable hepatoprotective plants - how can we optimize waste free uses of such highly versatile resources? Front. Pharmacol. 12, 738504. 10.3389/fphar.2021.738504", "ArticleIdList": ["10.3389/fphar.2021.738504", "PMC8637540", "34867345"]}, {"Citation": "Kurokawa H., Lenferink A. E., Simpson J. F., Pisacane P. I., Sliwkowski M. X., Forbes J. T., et al. (2000). Inhibition of HER2/neu (erbB-2) and mitogen-activated protein kinases enhances tamoxifen action against HER2-overexpressing, tamoxifen-resistant breast cancer cells. Cancer Res. 60 (20), 5887\u20135894.", "ArticleIdList": ["11059787"]}, {"Citation": "Kwon D. Y., Jung Y. S., Kim S. J., Kim Y. S., Choi D. W., Kim Y. C. (2013). Alterations in sulfur amino acid metabolism in mice treated with silymarin: a novel mechanism of its action involved in enhancement of the antioxidant defense in liver. Planta Med. 79 (12), 997\u20131002. 10.1055/s-0032-1328704", "ArticleIdList": ["10.1055/s-0032-1328704", "23807810"]}, {"Citation": "Lashgarian H. E., Adamii V., Ghorbanzadeh V., Chodari L., Kamali F., Akbari S., et al. (2020). Silibinin inhibit cell migration through downregulation of RAC1 gene expression in highly metastatic breast cancer cell line. Drug Res. (Stuttg) 70 (10), 478\u2013483. 10.1055/a-1223-1734", "ArticleIdList": ["10.1055/a-1223-1734", "32791535"]}, {"Citation": "Lau E. Y., Lo J., Cheng B. Y., Ma M. K., Lee J. M., Ng J. K., et al. (2016). Cancer-associated fibroblasts regulate tumor-initiating cell plasticity in hepatocellular carcinoma through c-met/FRA1/HEY1 signaling. Cell Rep. 15 (6), 1175\u20131189. 10.1016/j.celrep.2016.04.019", "ArticleIdList": ["10.1016/j.celrep.2016.04.019", "27134167"]}, {"Citation": "Li B., Shimizu Y., Kobayashi T., Terada N., Yoshimura K., Kamba T., et al. (2012). Overexpression of ETS-1 is associated with malignant biological features of prostate cancer. Asian J. Androl. 14 (6), 860\u2013863. 10.1038/aja.2012.107", "ArticleIdList": ["10.1038/aja.2012.107", "PMC3720114", "23064684"]}, {"Citation": "Li F., Sun Y., Jia J., Yang C., Tang X., Jin B., et al. (2018). Silibinin attenuates TGF-\u03b21-induced migration and invasion via EMT suppression and is associated with COX-2 downregulation in bladder transitional cell carcinoma. Oncol. Rep. 40 (6), 3543\u20133550. 10.3892/or.2018.6728", "ArticleIdList": ["10.3892/or.2018.6728", "30272315"]}, {"Citation": "Li H. B., Yang Y. R., Mo Z. J., Ding Y., Jiang W. J. (2015). Silibinin improves palmitate-induced insulin resistance in C2C12 myotubes by attenuating IRS-1/PI3K/Akt pathway inhibition. Braz J. Med. Biol. Res. 48 (5), 440\u2013446. 10.1590/1414-431x20144238", "ArticleIdList": ["10.1590/1414-431x20144238", "PMC4445668", "25760026"]}, {"Citation": "Li S., Mai S., Lin Y., Zhang J., He L., Zhang X., et al. (2022a). Effect and mechanism of silybin on protoporphyrin \u2168 in INH/RFP induced liver injury model. Anat. Res. 44 (02), 151\u2013155. 10.20021/j.cnki.1671-0770.2022.009", "ArticleIdList": ["10.20021/j.cnki.1671-0770.2022.009"]}, {"Citation": "Li W., Qu X., Kang X., Zhang H., Zhang X., Hu H., et al. (2022b). Silibinin eliminates mitochondrial ROS and restores autophagy through IL6ST/JAK2/STAT3 signaling pathway to protect cardiomyocytes from doxorubicin-induced injury. Eur. J. Pharmacol. 929, 175153. 10.1016/j.ejphar.2022.175153", "ArticleIdList": ["10.1016/j.ejphar.2022.175153", "35839932"]}, {"Citation": "Li X., Zhou R., Han Y., Zeng J., Shi L., Mao Y., et al. (2023). Silibinin attenuates experimental periodontitis by downregulation of inflammation and oxidative stress. Oxid. Med. Cell Longev. 2023, 5617800. 10.1155/2023/5617800", "ArticleIdList": ["10.1155/2023/5617800", "PMC9946757", "36846719"]}, {"Citation": "Liu C. (2021). Study on extraction technology of milk thistle protein Functional evaluation and preparation of bread. M.S: Harbin University of Commerce."}, {"Citation": "Liu T., Zhang M., Wang Y. (2012). Effects of milk thistle residue compound feed on pork quality. Feed Ind. 33 (11), 18\u201320."}, {"Citation": "Liu Y., Liu Z., Zheng Y. (2016). Research progress of milk thistle. J. Ginseng Res. 28 (02), 55\u201358. 10.19403/j.cnki.1671-1521.2016.02.016", "ArticleIdList": ["10.19403/j.cnki.1671-1521.2016.02.016"]}, {"Citation": "Lu P., Mamiya T., Lu L. L., Mouri A., Zou L., Nagai T., et al. (2009). Silibinin prevents amyloid beta peptide-induced memory impairment and oxidative stress in mice. Br. J. Pharmacol. 157 (7), 1270\u20131277. 10.1111/j.1476-5381.2009.00295.x", "ArticleIdList": ["10.1111/j.1476-5381.2009.00295.x", "PMC2743846", "19552690"]}, {"Citation": "Lv Y., Gao S., Xu S., Du G., Zhou J., Chen J. (2017). Spatial organization of silybin biosynthesis in milk thistle [Silybum marianum (L.) Gaertn]. Plant J. 92 (6), 995\u20131004. 10.1111/tpj.13736", "ArticleIdList": ["10.1111/tpj.13736", "28990236"]}, {"Citation": "Ma X., Yu X., Li R., Cui J., Yu H., Ren L., et al. (2024). Berberine-silybin salt achieves improved anti-nonalcoholic fatty liver disease effect through regulating lipid metabolism. J. Ethnopharmacol. 319 (Pt 2), 117238. 10.1016/j.jep.2023.117238", "ArticleIdList": ["10.1016/j.jep.2023.117238", "37774895"]}, {"Citation": "Ma Z., Liu W., Zeng J., Zhou J., Guo P., Xie H., et al. (2015). Silibinin induces apoptosis through inhibition of the mTOR-GLI1-BCL2 pathway in renal cell carcinoma. Oncol. Rep. 34 (5), 2461\u20132468. 10.3892/or.2015.4224", "ArticleIdList": ["10.3892/or.2015.4224", "26323996"]}, {"Citation": "MacDonald-Ramos K., Michan L., Martinez-Ibarra A., Cerbon M. (2021). Silymarin is an ally against insulin resistance: a review. Ann. Hepatol. 23, 100255. 10.1016/j.aohep.2020.08.072", "ArticleIdList": ["10.1016/j.aohep.2020.08.072", "32950646"]}, {"Citation": "MacDonald-Ramos K., Monroy A., Bobadilla-Bravo M., Cerbon M. (2024). Silymarin reduced insulin resistance in non-diabetic women with obesity. Int. J. Mol. Sci. 25 (4), 2050. 10.3390/ijms25042050", "ArticleIdList": ["10.3390/ijms25042050", "PMC10888588", "38396727"]}, {"Citation": "Mao J. T., Xue B., Lu Q. Y., Lundmark L., Burns W., Yang J., et al. (2023). Combinations of grape seed procyanidin extract and milk thistle silymarin extract against lung cancer - the role of MiR-663a and FHIT. Life Sci. 318, 121492. 10.1016/j.lfs.2023.121492", "ArticleIdList": ["10.1016/j.lfs.2023.121492", "36775115"]}, {"Citation": "Marengo A., Rosso C., Bugianesi E. (2016). Liver cancer: connections with obesity, fatty liver, and cirrhosis. Annu. Rev. Med. 67, 103\u2013117. 10.1146/annurev-med-090514-013832", "ArticleIdList": ["10.1146/annurev-med-090514-013832", "26473416"]}, {"Citation": "Marmouzi I., Bouyahya A., Ezzat S. M., El Jemli M., Kharbach M. (2021). The food plant Silybum marianum (L.) Gaertn.: phytochemistry, Ethnopharmacology and clinical evidence. J. Ethnopharmacol. 265, 113303. 10.1016/j.jep.2020.113303", "ArticleIdList": ["10.1016/j.jep.2020.113303", "32877720"]}, {"Citation": "Martinelli T. (2019). Identification of milk thistle shatter\u2010resistant mutant lines with altered lignocellulosic profile for the complete domestication of the species. Crop Sci. 59 (5), 2119\u20132127. 10.2135/cropsci2019.02.0103", "ArticleIdList": ["10.2135/cropsci2019.02.0103"]}, {"Citation": "Martinelli T., Whittaker A., Benedettelli S., Carboni A., Andrzejewska J. (2017). The study of flavonolignan association patterns in fruits of diverging Silybum marianum (L.) Gaertn. chemotypes provides new insights into the silymarin biosynthetic pathway. Phytochemistry 144, 9\u201318. 10.1016/j.phytochem.2017.08.013", "ArticleIdList": ["10.1016/j.phytochem.2017.08.013", "28863306"]}, {"Citation": "Matsumura Y., Ananthaswamy H. N. (2004). Toxic effects of ultraviolet radiation on the skin. Toxicol. Appl. Pharmacol. 195 (3), 298\u2013308. 10.1016/j.taap.2003.08.019", "ArticleIdList": ["10.1016/j.taap.2003.08.019", "15020192"]}, {"Citation": "Mi X. J., Choi H. S., Perumalsamy H., Shanmugam R., Thangavelu L., Balusamy S. R., et al. (2022). Biosynthesis and cytotoxic effect of silymarin-functionalized selenium nanoparticles induced autophagy mediated cellular apoptosis via downregulation of PI3K/Akt/mTOR pathway in gastric cancer. Phytomedicine 99, 154014. 10.1016/j.phymed.2022.154014", "ArticleIdList": ["10.1016/j.phymed.2022.154014", "35247670"]}, {"Citation": "Miranda L. M. O., Agostini L. D. C., Lima W. G., Camini F. C., Costa D. C. (2020). Silymarin attenuates hepatic and pancreatic redox imbalance independent of glycemic regulation in the alloxan-induced diabetic rat model. Biomed. Environ. Sci. 33 (9), 690\u2013700. 10.3967/bes2020.090", "ArticleIdList": ["10.3967/bes2020.090", "33106214"]}, {"Citation": "Morazzoni P., Bombardelli E. (1995). Silybum marianum (Carduus marianus)."}, {"Citation": "Morishima C., Shuhart M. C., Wang C. C., Paschal D. M., Apodaca M. C., Liu Y., et al. (2010). Silymarin inhibits in vitro T-cell proliferation and cytokine production in hepatitis C virus infection. Gastroenterology 138 (2), 671\u2013681. 10.1053/j.gastro.2009.09.021", "ArticleIdList": ["10.1053/j.gastro.2009.09.021", "PMC2819600", "19782083"]}, {"Citation": "Mueller A., Odze R., Jenkins T. D., Shahsesfaei A., Nakagawa H., Inomoto T., et al. (1997). A transgenic mouse model with cyclin D1 overexpression results in cell cycle, epidermal growth factor receptor, and p53 abnormalities. Cancer Res. 57 (24), 5542\u20135549.", "ArticleIdList": ["9407965"]}, {"Citation": "Mukhtar S., Xiaoxiong Z., Qamer S., Saad M., Mubarik M. S., Mahmoud A. H., et al. (2021). Hepatoprotective activity of silymarin encapsulation against hepatic damage in albino rats. Saudi J. Biol. Sci. 28 (1), 717\u2013723. 10.1016/j.sjbs.2020.10.063", "ArticleIdList": ["10.1016/j.sjbs.2020.10.063", "PMC7783827", "33424359"]}, {"Citation": "Nazir S. U., Kumar R., Singh A., Khan A., Tanwar P., Tripathi R., et al. (2019). Breast cancer invasion and progression by MMP-9 through Ets-1 transcription factor. Gene 711, 143952. 10.1016/j.gene.2019.143952", "ArticleIdList": ["10.1016/j.gene.2019.143952", "31265880"]}, {"Citation": "Nichols J. A., Katiyar S. K. (2010). Skin photoprotection by natural polyphenols: anti-inflammatory, antioxidant and DNA repair mechanisms. Arch. Dermatol Res. 302 (2), 71\u201383. 10.1007/s00403-009-1001-3", "ArticleIdList": ["10.1007/s00403-009-1001-3", "PMC2813915", "19898857"]}, {"Citation": "Nusse R., Clevers H. (2017). Wnt/\u03b2-Catenin signaling, disease, and emerging therapeutic modalities. Cell 169 (6), 985\u2013999. 10.1016/j.cell.2017.05.016", "ArticleIdList": ["10.1016/j.cell.2017.05.016", "28575679"]}, {"Citation": "Papadimou S. G., Golia E. E. (2024). Green and sustainable practices for an energy plant cultivation on naturally contaminated versus spiked soils. The impact of ageing soil pollution in the circular economy framework. Environ. Res. 246, 118130. 10.1016/j.envres.2024.118130", "ArticleIdList": ["10.1016/j.envres.2024.118130", "38191042"]}, {"Citation": "Pelter A., H\u00e4nsel R. (1968). The structure of silybin (silybum substance E6), the first flavonolignan. Tetrahedron Lett. 9 (25), 2911\u20132916. 10.1016/S0040-4039(00)89610-0", "ArticleIdList": ["10.1016/S0040-4039(00)89610-0"]}, {"Citation": "Pelter A., Hansel R., Kaloga M. (1977). The structure of silychristine. Tetrahedron Lett. 18 (51), 4547\u20134548. 10.1016/S0040-4039(01)83563-2", "ArticleIdList": ["10.1016/S0040-4039(01)83563-2"]}, {"Citation": "Peng R., Wang S., Wang R., Wang Y., Wu Y., Yuan Y. (2017). Antifibrotic effects of tanshinol in experimental hepatic fibrosis by targeting PI3K/AKT/mTOR/p70S6K1 signaling pathways. Discov. Med. 23 (125), 81\u201394.", "ArticleIdList": ["28371611"]}, {"Citation": "Pereira C., Barreira J. C., Calhelha R. C., Lopes M., Queiroz M. J., Vilas-Boas M., et al. (2015). Is honey able to potentiate the antioxidant and cytotoxic properties of medicinal plants consumed as infusions for hepatoprotective effects? Food Funct. 6 (5), 1435\u20131442. 10.1039/c4fo01206b", "ArticleIdList": ["10.1039/c4fo01206b", "25800338"]}, {"Citation": "Pferschy-Wenzig E. M., Kunert O., Thumann T., Moissl-Eichinger C., Bauer R. (2023). Characterization of metabolites from milk thistle flavonolignans generated by human fecal microbiota. Phytochemistry 215, 113834. 10.1016/j.phytochem.2023.113834", "ArticleIdList": ["10.1016/j.phytochem.2023.113834", "37648045"]}, {"Citation": "Poluha W., Poluha D. K., Chang B., Crosbie N. E., Schonhoff C. M., Kilpatrick D. L., et al. (1996). The cyclin-dependent kinase inhibitor p21 (WAF1) is required for survival of differentiating neuroblastoma cells. Mol. Cell Biol. 16 (4), 1335\u20131341. 10.1128/mcb.16.4.1335", "ArticleIdList": ["10.1128/mcb.16.4.1335", "PMC231117", "8657106"]}, {"Citation": "Polyak K., Kato J. Y., Solomon M. J., Sherr C. J., Massague J., Roberts J. M., et al. (1994). p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest. Genes Dev. 8 (1), 9\u201322. 10.1101/gad.8.1.9", "ArticleIdList": ["10.1101/gad.8.1.9", "8288131"]}, {"Citation": "Polyak S. J., Morishima C., Shuhart M. C., Wang C. C., Liu Y., Lee D. Y. (2007). Inhibition of T-cell inflammatory cytokines, hepatocyte NF-kappaB signaling, and HCV infection by standardized Silymarin. Gastroenterology 132 (5), 1925\u20131936. 10.1053/j.gastro.2007.02.038", "ArticleIdList": ["10.1053/j.gastro.2007.02.038", "17484885"]}, {"Citation": "Pradhan S. C., Girish C. (2006). Hepatoprotective herbal drug, silymarin from experimental pharmacology to clinical medicine. Indian J. Med. Res. 124 (5), 491\u2013504.", "ArticleIdList": ["17213517"]}, {"Citation": "Rahnama S., Tehrankhah Z. M., Mohajerani F., Mohammadi F. S., Yeganeh Z. Y., Najafi F., et al. (2023). Milk thistle nano-micelle formulation promotes cell cycle arrest and apoptosis in hepatocellular carcinoma cells through modulating miR-155-3p/SOCS2/PHLDA1 signaling axis. BMC Complement. Med. Ther. 23 (1), 337. 10.1186/s12906-023-04168-5", "ArticleIdList": ["10.1186/s12906-023-04168-5", "PMC10521506", "37749575"]}, {"Citation": "Ramasamy K., Agarwal R. (2008). Multitargeted therapy of cancer by silymarin. Cancer Lett. 269 (2), 352\u2013362. 10.1016/j.canlet.2008.03.053", "ArticleIdList": ["10.1016/j.canlet.2008.03.053", "PMC2612997", "18472213"]}, {"Citation": "Rambaldi A., Jacobs B. P., Gluud C. (2007). Milk thistle for alcoholic and/or hepatitis B or C virus liver diseases. Cochrane Database Syst. Rev. 2007 (4), Cd003620. 10.1002/14651858.CD003620.pub3", "ArticleIdList": ["10.1002/14651858.CD003620.pub3", "PMC8724782", "17943794"]}, {"Citation": "Raouf A., Li V., Kola I., Watson D. K., Seth A. (2000). The Ets1 proto-oncogene is upregulated by retinoic acid: characterization of a functional retinoic acid response element in the Ets1 promoter. Oncogene 19 (15), 1969\u20131974. 10.1038/sj.onc.1203505", "ArticleIdList": ["10.1038/sj.onc.1203505", "10773887"]}, {"Citation": "Ros\u00e1rio M., Birchmeier W. (2003). How to make tubes: signaling by the Met receptor tyrosine kinase. Trends Cell Biol. 13 (6), 328\u2013335. 10.1016/s0962-8924(03)00104-1", "ArticleIdList": ["10.1016/s0962-8924(03)00104-1", "12791299"]}, {"Citation": "Saller R., Brignoli R., Melzer J., Meier R. (2008). An updated systematic review with meta-analysis for the clinical evidence of silymarin. Forsch Komplementmed 15 (1), 9\u201320. 10.1159/000113648", "ArticleIdList": ["10.1159/000113648", "18334810"]}, {"Citation": "Saller R., Meier R., Brignoli R. (2001). The use of silymarin in the treatment of liver diseases. Drugs 61 (14), 2035\u20132063. 10.2165/00003495-200161140-00003", "ArticleIdList": ["10.2165/00003495-200161140-00003", "11735632"]}, {"Citation": "Salomone F., Barbagallo I., Godos J., Lembo V., Currenti W., Cin\u00e0 D., et al. (2017). Silibinin restores NAD\u207a levels and induces the SIRT1/AMPK pathway in non-alcoholic fatty liver. Nutrients 9 (10), 1086. 10.3390/nu9101086", "ArticleIdList": ["10.3390/nu9101086", "PMC5691703", "28973994"]}, {"Citation": "Sayeed M. M. (1998). Neutrophil signaling alteration: an adverse inflammatory response after burn shock. Med. (B Aires) 58 (4), 386\u2013392.", "ArticleIdList": ["9816701"]}, {"Citation": "Sayyed A., Heuertz R., Ezekiel U. R. (2022). Curcumin, but not its degradation products, in combination with silibinin is primarily responsible for the inhibition of colon cancer cell proliferation. Micropubl. Biol. 2022. 10.17912/micropub.biology.000617", "ArticleIdList": ["10.17912/micropub.biology.000617", "PMC9372765", "35966396"]}, {"Citation": "Schwacha M. G., Chaudry I. H. (2002). The cellular basis of post-burn immunosuppression: macrophages and mediators. Int. J. Mol. Med. 10 (3), 239\u2013243.", "ArticleIdList": ["12165794"]}, {"Citation": "Sener G., Sehirli O., Cetinel S., Ercan F., Y\u00fcksel M., Gedik N., et al. (2005a). Amelioration of sepsis-induced hepatic and ileal injury in rats by the leukotriene receptor blocker montelukast. Prostagl. Leukot. Essent. Fat. Acids 73 (6), 453\u2013462. 10.1016/j.plefa.2005.07.008", "ArticleIdList": ["10.1016/j.plefa.2005.07.008", "16162403"]}, {"Citation": "Sener G., Toklu H., Ercan F., Erkanli G. (2005b). Protective effect of beta-glucan against oxidative organ injury in a rat model of sepsis. Int. Immunopharmacol. 5 (9), 1387\u20131396. 10.1016/j.intimp.2005.03.007", "ArticleIdList": ["10.1016/j.intimp.2005.03.007", "15953565"]}, {"Citation": "Shaw R. J., Cantley L. C. (2006). Ras, PI(3)K and mTOR signalling controls tumour cell growth. Nature 441 (7092), 424\u2013430. 10.1038/nature04869", "ArticleIdList": ["10.1038/nature04869", "16724053"]}, {"Citation": "Sherr C. J. (1996). Cancer cell cycles. Science 274 (5293), 1672\u20131677. 10.1126/science.274.5293.1672", "ArticleIdList": ["10.1126/science.274.5293.1672", "8939849"]}, {"Citation": "Shin S., Lee J. A., Kim M., Kum H., Jung E., Park D. (2015). Anti-glycation activities of phenolic constituents from Silybum marianum (Milk Thistle) flower in vitro and on human explants. Molecules 20 (3), 3549\u20133564. 10.3390/molecules20033549", "ArticleIdList": ["10.3390/molecules20033549", "PMC6272457", "25706757"]}, {"Citation": "Singh R. P., Agarwal R. (2009). Cosmeceuticals and silibinin. Clin. Dermatol 27 (5), 479\u2013484. 10.1016/j.clindermatol.2009.05.012", "ArticleIdList": ["10.1016/j.clindermatol.2009.05.012", "PMC2767273", "19695480"]}, {"Citation": "Singh R. P., Deep G., Chittezhath M., Kaur M., Dwyer-Nield L. D., Malkinson A. M., et al. (2006). Effect of silibinin on the growth and progression of primary lung tumors in mice. J. Natl. Cancer Inst. 98 (12), 846\u2013855. 10.1093/jnci/djj231", "ArticleIdList": ["10.1093/jnci/djj231", "16788158"]}, {"Citation": "Singh R. P., Dhanalakshmi S., Agarwal R. (2002). Phytochemicals as cell cycle modulators--a less toxic approach in halting human cancers. Cell Cycle 1 (3), 155\u2013160. 10.4161/cc.1.3.117", "ArticleIdList": ["10.4161/cc.1.3.117", "12429925"]}, {"Citation": "Singhal N. K., Srivastava G., Patel D. K., Jain S. K., Singh M. P. (2011). Melatonin or silymarin reduces maneb- and paraquat-induced Parkinson's disease phenotype in the mouse. J. Pineal Res. 50 (2), 97\u2013109. 10.1111/j.1600-079X.2010.00819.x", "ArticleIdList": ["10.1111/j.1600-079X.2010.00819.x", "20964710"]}, {"Citation": "Song X. (2023). Protective effect of silybin on hepatocyte injury induced by ethanol or acetaldehyde. Shenyang Pharmaceutical University."}, {"Citation": "Soto C., Mena R., Luna J., Cerb\u00f3n M., Larrieta E., Vital P., et al. (2004). Silymarin induces recovery of pancreatic function after alloxan damage in rats. Life Sci. 75 (18), 2167\u20132180. 10.1016/j.lfs.2004.04.019", "ArticleIdList": ["10.1016/j.lfs.2004.04.019", "15325843"]}, {"Citation": "Soto C., P\u00e9rez J., Garc\u00eda V., Ur\u00eda E., Vadillo M., Raya L. (2010). Effect of silymarin on kidneys of rats suffering from alloxan-induced diabetes mellitus. Phytomedicine 17 (14), 1090\u20131094. 10.1016/j.phymed.2010.04.011", "ArticleIdList": ["10.1016/j.phymed.2010.04.011", "20579862"]}, {"Citation": "Soto C., Recoba R., Barr\u00f3n H., Alvarez C., Favari L. (2003). Silymarin increases antioxidant enzymes in alloxan-induced diabetes in rat pancreas. Comp. Biochem. Physiol. C Toxicol. Pharmacol. 136 (3), 205\u2013212. 10.1016/s1532-0456(03)00214-x", "ArticleIdList": ["10.1016/s1532-0456(03)00214-x", "14659454"]}, {"Citation": "Soto C. P., Perez B. L., Favari L. P., Reyes J. L. (1998). Prevention of alloxan-induced diabetes mellitus in the rat by silymarin. Comp. Biochem. Physiol. C Pharmacol. Toxicol. Endocrinol. 119 (2), 125\u2013129. 10.1016/s0742-8413(97)00198-9", "ArticleIdList": ["10.1016/s0742-8413(97)00198-9", "9669080"]}, {"Citation": "Stastnik O., Pavlata L., Mrkvicova E. (2020). The milk thistle seed cakes and hempseed cakes are potential feed for poultry. Anim. (Basel) 10 (8), 1384. 10.3390/ani10081384", "ArticleIdList": ["10.3390/ani10081384", "PMC7459908", "32785057"]}, {"Citation": "Stolf A. M., Cardoso C. C., Acco A. (2017). Effects of silymarin on diabetes mellitus complications: a review. Phytotherapy Res. 31 (3), 366\u2013374. 10.1002/ptr.5768", "ArticleIdList": ["10.1002/ptr.5768", "28124457"]}, {"Citation": "Sun R., Xu D., Wei Q., Zhang B., Aa J., Wang G., et al. (2020). Silybin ameliorates hepatic lipid accumulation and modulates global metabolism in an NAFLD mouse model. Biomed. Pharmacother. 123, 109721. 10.1016/j.biopha.2019.109721", "ArticleIdList": ["10.1016/j.biopha.2019.109721", "31865143"]}, {"Citation": "Surai P. (2015). Silymarin as a natural antioxidant: an overview of the current evidence and perspectives. Antioxidants 4 (1), 204\u2013247. 10.3390/antiox4010204", "ArticleIdList": ["10.3390/antiox4010204", "PMC4665566", "26785346"]}, {"Citation": "Taghiabadi E., Imenshahidi M., Abnous K., Mosafa F., Sankian M., Memar B., et al. (2012). Protective effect of silymarin against acrolein-induced cardiotoxicity in mice. Evidence-Based Complementary Altern. Med. 2012, 352091\u2013352114. 10.1155/2012/352091", "ArticleIdList": ["10.1155/2012/352091", "PMC3535759", "23320028"]}, {"Citation": "Tan M., Jing T., Lan K. H., Neal C. L., Li P., Lee S., et al. (2002). Phosphorylation on tyrosine-15 of p34(Cdc2) by ErbB2 inhibits p34(Cdc2) activation and is involved in resistance to taxol-induced apoptosis. Mol. Cell 9 (5), 993\u20131004. 10.1016/s1097-2765(02)00510-5", "ArticleIdList": ["10.1016/s1097-2765(02)00510-5", "12049736"]}, {"Citation": "Templeton A. J., Diez-Gonzalez L., Ace O., Vera-Badillo F., Seruga B., Jord\u00e1n J., et al. (2014). Prognostic relevance of receptor tyrosine kinase expression in breast cancer: a meta-analysis. Cancer Treat. Rev. 40 (9), 1048\u20131055. 10.1016/j.ctrv.2014.08.003", "ArticleIdList": ["10.1016/j.ctrv.2014.08.003", "25217796"]}, {"Citation": "Toklu H. Z., Tunal\u0131-Akbay T., Erkanl\u0131 G., Y\u00fcksel M., Ercan F., \u015eener G. (2007). Silymarin, the antioxidant component of Silybum marianum, protects against burn-induced oxidative skin injury. Burns 33 (7), 908\u2013916. 10.1016/j.burns.2006.10.407", "ArticleIdList": ["10.1016/j.burns.2006.10.407", "17521818"]}, {"Citation": "Toklu H. Z., Tunali Akbay T., Velioglu-Ogunc A., Ercan F., Gedik N., Keyer-Uysal M., et al. (2008). Silymarin, the antioxidant component of Silybum marianum, prevents sepsis-induced acute lung and brain injury. J. Surg. Res. 145 (2), 214\u2013222. 10.1016/j.jss.2007.03.072", "ArticleIdList": ["10.1016/j.jss.2007.03.072", "17950327"]}, {"Citation": "Tyagi A., Agarwal C., Harrison G., Glode L. M., Agarwal R. (2004). Silibinin causes cell cycle arrest and apoptosis in human bladder transitional cell carcinoma cells by regulating CDKI-CDK-cyclin cascade, and caspase 3 and PARP cleavages. Carcinogenesis 25 (9), 1711\u20131720. 10.1093/carcin/bgh180", "ArticleIdList": ["10.1093/carcin/bgh180", "15117815"]}, {"Citation": "Tyagi A., Singh R. P., Ramasamy K., Raina K., Redente E. F., Dwyer-Nield L. D., et al. (2009). Growth inhibition and regression of lung tumors by silibinin: modulation of angiogenesis by macrophage-associated cytokines and nuclear factor-kappaB and signal transducers and activators of transcription 3. Cancer Prev. Res. (Phila) 2 (1), 74\u201383. 10.1158/1940-6207.Capr-08-0095", "ArticleIdList": ["10.1158/1940-6207.Capr-08-0095", "PMC2615181", "19139021"]}, {"Citation": "Verdura S., Cuy\u00e0s E., Ruiz-Torres V., Micol V., Joven J., Bosch-Barrera J., et al. (2021). Lung cancer management with silibinin: a historical and translational perspective. Pharmaceuticals 14 (6), 559. 10.3390/ph14060559", "ArticleIdList": ["10.3390/ph14060559", "PMC8230811", "34208282"]}, {"Citation": "Wagner H., H\u00f6rhammer L., Seitz M. (1968). Chemical evaluation of a silymarin-containing flavonoid concentrate from Silybum marianum (L.) Gaertn. Arzneimittelforschung 18 (6), 696\u2013698.", "ArticleIdList": ["5755806"]}, {"Citation": "Wagner H., Seligmann O., H\u00f6rhammer L., Seitz M., Sonnenbichler J. (1971). Zur struktur von silychristin, einem zweiten silymarin-isomeren aus silybum marianum. Tetrahedron Lett. 12 (22), 1895\u20131899. 10.1016/S0040-4039(01)96737-1", "ArticleIdList": ["10.1016/S0040-4039(01)96737-1"]}, {"Citation": "Wagner H., Seligmann O., Seitz M., Abraham D., Sonnenbichler J. (1976). Notizen: Silydianin und Silychristin, zwei isomere Silymarine aus Silybum marianum L. Gaertn. (Mariendistel)/Silydianin and Silychristin, two Isomeric Silymarins from Silybum marianum L. Gaertn. (milk thistle), zwei isomere Silymarine aus Silybum marianum L. Gaertn. (Mariendistel)/Silydianin Silychristin, two Isomeric Silymarins Silybum marianum L. Gaertn. (milk thistle). 31(6), 876\u2013884. 10.1515/znb-1976-0630", "ArticleIdList": ["10.1515/znb-1976-0630"]}, {"Citation": "Wagoner J., Negash A., Kane O. J., Martinez L. E., Nahmias Y., Bourne N., et al. (2010). Multiple effects of silymarin on the hepatitis C virus lifecycle. Hepatology 51 (6), 1912\u20131921. 10.1002/hep.23587", "ArticleIdList": ["10.1002/hep.23587", "PMC2909978", "20512985"]}, {"Citation": "Wang J., Zhang L., Cao H., Shi X., Zhang X., Gao Z., et al. (2022). Silibinin improves L-cell mass and function through an estrogen receptor-mediated antioxidative mechanism. Phytomedicine 99, 154022. 10.1016/j.phymed.2022.154022", "ArticleIdList": ["10.1016/j.phymed.2022.154022", "35255283"]}, {"Citation": "Wang L. G., Liu X. M., Kreis W., Budman D. R. (1997). Down-regulation of prostate-specific antigen expression by finasteride through inhibition of complex formation between androgen receptor and steroid receptor-binding consensus in the promoter of the PSA gene in LNCaP cells. Cancer Res. 57 (4), 714\u2013719.", "ArticleIdList": ["9044850"]}, {"Citation": "Wang M. J., Lin W. W., Chen H. L., Chang Y. H., Ou H. C., Kuo J. S., et al. (2002). Silymarin protects dopaminergic neurons against lipopolysaccharide-induced neurotoxicity by inhibiting microglia activation. Eur. J. Neurosci. 16 (11), 2103\u20132112. 10.1046/j.1460-9568.2002.02290.x", "ArticleIdList": ["10.1046/j.1460-9568.2002.02290.x", "12473078"]}, {"Citation": "Wang X., Zhang Z., Wu S.-C. (2020a). Health benefits of Silybum marianum: phytochemistry, pharmacology, and applications. J. Agric. Food Chem. 68 (42), 11644\u201311664. 10.1021/acs.jafc.0c04791", "ArticleIdList": ["10.1021/acs.jafc.0c04791", "33045827"]}, {"Citation": "Wang X., Zhang Z., Wu S. C. (2020b). Health benefits of Silybum marianum: phytochemistry, pharmacology, and applications. J. Agric. Food Chem. 68 (42), 11644\u201311664. 10.1021/acs.jafc.0c04791", "ArticleIdList": ["10.1021/acs.jafc.0c04791", "33045827"]}, {"Citation": "Wang Y. (2023). Inhibition of oxidative stress by rnai targeting cyp2e1 alleviates alcoholic liver disease a in mice. Jiangsu University."}, {"Citation": "Wei P., Li X., Wang S., Dong Y., Yin H., Gu Z., et al. (2022). Silibinin ameliorates formaldehyde-induced cognitive impairment by inhibiting oxidative stress. Oxid. Med. Cell Longev. 2022, 5981353. 10.1155/2022/5981353", "ArticleIdList": ["10.1155/2022/5981353", "PMC9225847", "35757504"]}, {"Citation": "Wei Y., Zhuang Y., Zhang Y., Luo L., Yu B., Zeng J. (2024). Role of heat shock protein 70 in silibinin-induced apoptosis in bladder cancer. J. Cancer 15 (1), 79\u201389. 10.7150/jca.88668", "ArticleIdList": ["10.7150/jca.88668", "PMC10751677", "38164275"]}, {"Citation": "Wianowska D., Wi\u015bniewski M. (2015). Simplified procedure of silymarin extraction from Silybum marianum L. Gaertner. J. Chromatogr. Sci. 53 (2), 366\u2013372. 10.1093/chromsci/bmu049", "ArticleIdList": ["10.1093/chromsci/bmu049", "24895445"]}, {"Citation": "Wu J., Lou Y. G., Yang X. L., Wang R., Zhang R., Aa J. Y., et al. (2023a). Silybin regulates P450s activity by attenuating endoplasmic reticulum stress in mouse nonalcoholic fatty liver disease. Acta Pharmacol. Sin. 44 (1), 133\u2013144. 10.1038/s41401-022-00924-4", "ArticleIdList": ["10.1038/s41401-022-00924-4", "PMC9813371", "35705686"]}, {"Citation": "Wu S., Chen G., Chen E. Y., Farshidpour L. S., Zhang Q., Wang G., et al. (2023b). Core structure-activity relationship studies of 5,7,20-O-trimethylsilybins in prostate cancer cell models. Pharm. (Basel) 16 (4), 531. 10.3390/ph16040531", "ArticleIdList": ["10.3390/ph16040531", "PMC10145751", "37111288"]}, {"Citation": "Xu R., Qiu S., Zhang J., Liu X., Zhang L., Xing H., et al. (2022). Silibinin schiff base derivatives counteract CCl(4)-induced acute liver injury by enhancing anti-inflammatory and antiapoptotic bioactivities. Drug Des. Devel Ther. 16, 1441\u20131456. 10.2147/dddt.S356847", "ArticleIdList": ["10.2147/dddt.S356847", "PMC9122151", "35601675"]}, {"Citation": "Yang J., Liang J., Shao L., Liu L., Gao K., Zhang J.-L., et al. (2020). Green production of silybin and isosilybin by merging metabolic engineering approaches and enzymatic catalysis. Metab. Eng. 59, 44\u201352. 10.1016/j.ymben.2020.01.007", "ArticleIdList": ["10.1016/j.ymben.2020.01.007", "32004707"]}, {"Citation": "Yassin N. Y. S., AbouZid S. F., El-Kalaawy A. M., Ali T. M., Almehmadi M. M., Ahmed O. M. (2022). Silybum marianum total extract, silymarin and silibinin abate hepatocarcinogenesis and hepatocellular carcinoma growth via modulation of the HGF/c-Met, Wnt/\u03b2-catenin, and PI3K/Akt/mTOR signaling pathways. Biomed. Pharmacother. 145, 112409. 10.1016/j.biopha.2021.112409", "ArticleIdList": ["10.1016/j.biopha.2021.112409", "34781148"]}, {"Citation": "Yassin N. Y. S., AbouZid S. F., El-Kalaawy A. M., Ali T. M., Elesawy B. H., Ahmed O. M. (2021). Tackling of renal carcinogenesis in wistar rats by Silybum marianum total extract, silymarin, and silibinin via modulation of oxidative stress, apoptosis, Nrf2, PPAR\u03b3, NF-\u03baB, and PI3K/Akt signaling pathways. Oxid. Med. Cell Longev. 2021, 7665169. 10.1155/2021/7665169", "ArticleIdList": ["10.1155/2021/7665169", "PMC8497111", "34630852"]}, {"Citation": "Yasuda M., Shimizu I., Shiba M., Ito S. (1999). Suppressive effects of estradiol on dimethylnitrosamine-induced fibrosis of the liver in rats. Hepatology 29 (3), 719\u2013727. 10.1002/hep.510290307", "ArticleIdList": ["10.1002/hep.510290307", "10051473"]}, {"Citation": "Yoshida A., Hsu L. C., Dav\u00e9 V. (1992). Retinal oxidation activity and biological role of human cytosolic aldehyde dehydrogenase. Enzyme 46 (4-5), 239\u2013244. 10.1159/000468794", "ArticleIdList": ["10.1159/000468794", "1292933"]}, {"Citation": "You Y., He Q., Lu H., Zhou X., Chen L., Liu H., et al. (2020). Silibinin induces G2/M cell cycle arrest by activating drp1-dependent mitochondrial fission in cervical cancer. Front. Pharmacol. 11, 271. 10.3389/fphar.2020.00271", "ArticleIdList": ["10.3389/fphar.2020.00271", "PMC7080994", "32226384"]}, {"Citation": "Youn C. K., Cho S. I., Lee M. Y., Jeon Y. J., Lee S. K. (2017). Inhibition of ERK1/2 by silymarin in mouse mesangial cells. Korean J. Physiol. Pharmacol. 21 (1), 117\u2013124. 10.4196/kjpp.2017.21.1.117", "ArticleIdList": ["10.4196/kjpp.2017.21.1.117", "PMC5214903", "28066148"]}, {"Citation": "Yu H., Saif M. S., Hasan M., Zafar A., Zhao X., Waqas M., et al. (2023). Designing a silymarin nanopercolating system using CME@ZIF-8: an approach to hepatic injuries. ACS Omega 8 (50), 48535\u201348548. 10.1021/acsomega.3c08494", "ArticleIdList": ["10.1021/acsomega.3c08494", "PMC10734040", "38144097"]}, {"Citation": "Zappavigna S., Vanacore D., Lama S., Potenza N., Russo A., Ferranti P., et al. (2019). Silybin-induced apoptosis occurs in parallel to the increase of ceramides synthesis and miRNAs secretion in human hepatocarcinoma cells. Int. J. Mol. Sci. 20 (9), 2190. 10.3390/ijms20092190", "ArticleIdList": ["10.3390/ijms20092190", "PMC6539179", "31058823"]}, {"Citation": "Zarrouk A., Martine L., Gr\u00e9goire S., Nury T., Meddeb W., Camus E., et al. (2019). Profile of fatty acids, tocopherols, phytosterols and polyphenols in mediterranean oils (argan oils, olive oils, milk thistle seed oils and nigella seed oil) and evaluation of their antioxidant and cytoprotective activities. Curr. Pharm. Des. 25 (15), 1791\u20131805. 10.2174/1381612825666190705192902", "ArticleIdList": ["10.2174/1381612825666190705192902", "31298157"]}, {"Citation": "Zhai S., Li N., Chen B., Kou J., Xing W., Zhang P. (2019). Research progress of milk thistle in the treatment of chronic hepatitis. Chin. J. Clin. Pharmacol. Ther. 24 (05), 573\u2013579."}, {"Citation": "Zhang C. (2011). Study on chemical constituents and antioxidant activities of milk thistle. M.S: Northwest A&F University."}, {"Citation": "Zhang M., Weng W., Zhang Q., Wu Y., Ni S., Tan C., et al. (2018a). The lncRNA NEAT1 activates Wnt/\u03b2-catenin signaling and promotes colorectal cancer progression via interacting with DDX5. J. Hematol. Oncol. 11 (1), 113. 10.1186/s13045-018-0656-7", "ArticleIdList": ["10.1186/s13045-018-0656-7", "PMC6125951", "30185232"]}, {"Citation": "Zhang R., Xu D., Zhang Y., Wang R., Yang N., Lou Y., et al. (2021). Silybin restored CYP3A expression through the sirtuin 2/nuclear factor \u03ba-B pathway in mouse nonalcoholic fatty liver disease. Drug Metab. Dispos. 49 (9), 770\u2013779. 10.1124/dmd.121.000438", "ArticleIdList": ["10.1124/dmd.121.000438", "34183378"]}, {"Citation": "Zhang Y., Ge Y., Chen Y., Li Q., Chen J., Dong Y., et al. (2012). Cellular and molecular mechanisms of silibinin induces cell-cycle arrest and apoptosis on HeLa cells. Cell Biochem. Funct. 30 (3), 243\u2013248. 10.1002/cbf.1842", "ArticleIdList": ["10.1002/cbf.1842", "22170400"]}, {"Citation": "Zhang Y., Ge Y., Ping X., Yu M., Lou D., Shi W. (2018b). Synergistic apoptotic effects of silibinin in enhancing paclitaxel toxicity in human gastric cancer cell lines. Mol. Med. Rep. 18 (2), 1835\u20131841. 10.3892/mmr.2018.9129", "ArticleIdList": ["10.3892/mmr.2018.9129", "29901126"]}, {"Citation": "Zhang Y., Hai J., Cao M., Zhang Y., Pei S., Wang J., et al. (2013a). Silibinin ameliorates steatosis and insulin resistance during non-alcoholic fatty liver disease development partly through targeting IRS-1/PI3K/Akt pathway. Int. Immunopharmacol. 17 (3), 714\u2013720. 10.1016/j.intimp.2013.08.019", "ArticleIdList": ["10.1016/j.intimp.2013.08.019", "24036369"]}, {"Citation": "Zhang Y., Li Q., Ge Y., Chen Y., Chen J., Dong Y., et al. (2013b). Silibinin triggers apoptosis and cell-cycle arrest of SGC7901 cells. Phytother. Res. 27 (3), 397\u2013403. 10.1002/ptr.4733", "ArticleIdList": ["10.1002/ptr.4733", "22619007"]}, {"Citation": "Zhao X., Wang B., Wang T., Li X. (2006). Inhibitory effects of silymarin on hepatic fibrosis induced by dimethylnitrosamine: experiment with rats. Chin. Med. J. 86 (36), 2563\u20132566.", "ArticleIdList": ["17198567"]}, {"Citation": "Zheng N., Liu L., Liu W.-w., Li F., Hayashi T., Tashiro S.-i., et al. (2016). Crosstalk of ROS/RNS and autophagy in silibinin-induced apoptosis of MCF-7 human breast cancer cells in vitro . Acta Pharmacol. Sin. 38 (2), 277\u2013289. 10.1038/aps.2016.117", "ArticleIdList": ["10.1038/aps.2016.117", "PMC5309753", "27867187"]}, {"Citation": "Zheng N., Liu L., Liu W. W., Li F., Hayashi T., Tashiro S. I., et al. (2017). Crosstalk of ROS/RNS and autophagy in silibinin-induced apoptosis of MCF-7 human breast cancer cells in vitro . Acta Pharmacol. Sin. 38 (2), 277\u2013289. 10.1038/aps.2016.117", "ArticleIdList": ["10.1038/aps.2016.117", "PMC5309753", "27867187"]}]}], "History": [{"Year": "2024", "Month": "4", "Day": "15"}, {"Year": "2024", "Month": "6", "Day": "20"}, {"Year": "2024", "Month": "7", "Day": "26", "Hour": "12", "Minute": "47"}, {"Year": "2024", "Month": "7", "Day": "26", "Hour": "12", "Minute": "46"}, {"Year": "2024", "Month": "7", "Day": "26", "Hour": "4", "Minute": "31"}, {"Year": "2024", "Month": "7", "Day": "11"}], "PublicationStatus": "epublish", "ArticleIdList": ["39055491", "PMC11269164", "10.3389/fphar.2024.1417655", "1417655"]}}]}